Wallace Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8M Sell
115,340
-69
-0.1% -$8.08K 13.94% 1
2026
Q1
$13.9M Sell
115,409
-21
-0% -$2.42K 14.83% 1
2025
Q4
$12.2M Sell
115,430
-234
-0.2% -$22K 12.75% 1
2025
Q3
$9.16M Sell
115,664
-349
-0.3% -$28.7K 7.36% 1
2025
Q2
$10.4M Buy
116,013
+53
+0% +$4.21K 7.56% 1
2025
Q1
$11.5M Buy
115,960
+204
+0.2% +$19K 7.98% 1
2024
Q4
$13.1M Buy
115,756
+53
+0% +$5.46K 9.09% 1
2024
Q3
$14.3M Sell
115,703
-41
-0% -$4.87K 10.48% 1
2024
Q2
$14.3M Sell
115,744
-724
-0.6% -$93.3K 10.31% 1
2024
Q1
$12.7M Sell
116,468
-510
-0.4% -$62.9K 9.54% 1
2023
Q4
$12M Buy
116,978
+12
+0% +$1.25K 9.43% 1
2023
Q3
$13.5M Sell
116,966
-477
-0.4% -$51.4K 9.69% 1
2023
Q2
$12.5M Hold
117,443
9.51% 1
2023
Q1
$12.5M Buy
117,443
+22
+0% +$2.38K 9.5% 1
2022
Q4
$13M Buy
+117,421
New +$12M 10.28% 1

Other funds holding MRK

Wallace Advisory Group's MRK Position: Q2 2026 in Review

Wallace Advisory Group reduced its Merck (MRK) stake by 0.06% in Q2 2026, selling an estimated $8.08K and leaving 115,340 shares worth $14.8M. The position accounts for 13.94% of the portfolio, ranked #1.

Wallace Advisory Group first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wallace Advisory Group held 115,340 shares of Merck worth $14.8M as of Q2 2026.
  • Wallace Advisory Group sold 69 Merck shares in Q2 2026, an estimated $8.08K.
  • Merck made up 13.94% of Wallace Advisory Group's portfolio in Q2 2026, its #1 holding.
  • Wallace Advisory Group first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wallace Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.